Skip to main navigation Skip to search Skip to main content

Rs2735383, located at a microRNA binding site in the 3'UTR of NBS1, is not associated with breast cancer risk

  • Jingjing Liu
  • , Ivona Loncar
  • , J. Margriet Colleé
  • , Manjeet K. Bolla
  • , Joe Dennis
  • , Kyriaki Michailidou
  • , Qin Wang
  • , Irene L. Andrulis
  • , Monica Barile
  • , Matthias W. Beckmann
  • , Sabine Behrens
  • , Javier Benitez
  • , Carl Blomqvist
  • , Bram Boeckx
  • , Natalia V. Bogdanova
  • , Stig E. Bojesen
  • , Hiltrud Brauch
  • , Paul Brennan
  • , Hermann Brenner
  • , Annegien Broeks
  • Barbara Burwinkel, Jenny Chang-Claude, Shou Tung Chen, Georgia Chenevix-Trench, Ching Y. Cheng, Ji Yeob Choi, Fergus J. Couch, Angela Cox, Simon S. Cross, Katarina Cuk, Kamila Czene, Thilo Dörk, Isabel Dos-Santos-Silva, Peter A. Fasching, Jonine Figueroa, Henrik Flyger, Montserrat Garciá-Closas, Graham G. Giles, Gord Glendon, Mark S. Goldberg, Anna González-Neira, Pascal Guénel, Christopher A. Haiman, Ute Hamann, Steven N. Hart, Mikael Hartman, Sigrid Hatse, John L. Hopper, Hidemi Ito, Anna Jakubowska, Maria Kabisch, Daehee Kang, Veli Matti Kosma, Vessela N. Kristensen, Loic Le Marchand, Eunjung Lee, Jingmei Li, Artitaya Lophatananon, Jan Lubinski, Arto Mannermaa, Keitaro Matsuo, Roger L. Milne, Susan L. Neuhausen, Heli Nevanlinna, Nick Orr, Jose I.A. Perez, Julian Peto, Thomas C. Putti, Katri Pylkäs, Paolo Radice, Suleeporn Sangrajrang, Elinor J. Sawyer, Marjanka K. Schmidt, Andreas Schneeweiss, Chen Yang Shen, Martha J. Shrubsole, Xiao Ou Shu, Jacques Simard, Melissa C. Southey, Anthony Swerdlow, Soo H. Teo, Daniel C. Tessier, Somchai Thanasitthichai, Ian Tomlinson, Diana Torres, Thérèse Truong, Chiu Chen Tseng, Celine Vachon, Robert Winqvist, Anna H. Wu, Drakoulis Yannoukakos, Wei Zheng, Per Hall, Alison M. Dunning, Douglas F. Easton, Maartje J. Hooning, Ans M.W. Van Den Ouweland, John W.M. Martens, Antoinette Hollestelle
  • Erasmus MC Cancer Institute
  • Erasmus University Rotterdam
  • University of Cambridge
  • Cyprus Institute of Neurology and Genetics
  • University of Toronto
  • European Institute of Oncology
  • Friedrich-Alexander University Erlangen-Nürnberg
  • German Cancer Research Center
  • University of Hamburg
  • Centro de Investigación en Red de Enfermedades Raras
  • Centre for Biomedical Research on Rare Diseases (CIBERER)
  • Helsinki University Hospital
  • Flanders Institute for Biotechnology
  • KU Leuven
  • Hannover Medical School
  • The N.N. Alexandrov Research Institute of Oncology and Medical Radiology
  • Copenhagen University Hospital – Herlev and Gentofte
  • University of Copenhagen
  • Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology
  • University of Tübingen
  • International Agency for Research on Cancer
  • Antoni van Leeuwenhoek Hospital
  • Heidelberg University 
  • Changhua Christian Hospital
  • Queensland Institute of Medical Research
  • Singapore National Eye Center
  • National University of Singapore
  • Duke-NUS Medical School
  • Seoul National University
  • Mayo Clinic Rochester, MN
  • University of Sheffield
  • Karolinska Institutet
  • London School of Hygiene and Tropical Medicine
  • University of California at Los Angeles
  • University of Edinburgh
  • National Cancer Institute (NCI)
  • Cancer Council Victoria
  • Centre for Epidemiology and Biostatistics
  • McGill University
  • McGill University Health Centre, Royal Victoria Hospital
  • Occupational and Social Determinants of Health
  • Keck School of Medicine of USC
  • MOH Holdings Pte Ltd.
  • University Hospitals Leuven
  • Aichi Cancer Center Hospital and Research Institute
  • Nagoya University
  • Pomeranian Medical University in Szczecin
  • University of Eastern Finland
  • University of Oslo
  • University of Hawaii Cancer Center
  • University of Warwick
  • University of Manchester
  • City of Hope National Med Center
  • Institute of Cancer Research
  • Hospital Monte Naranco
  • University of Oulu
  • Northern Finland Laboratory Centre Oulu
  • Istituto di Ricovero e Cura a Carattere Scientifico
  • The National Cancer Institute
  • Guy’s Hospital
  • China Medical University Taichung
  • Academia Sinica - Institute of Biomedical Sciences
  • Vanderbilt University Medical Center
  • Université Laval
  • University of Melbourne
  • Cancer Research Malaysia
  • University of Malaya
  • University of Oxford
  • Demokritos National Centre for Scientific Research
  • Cancer Genomics Netherlands

Research output: Contribution to journalArticlepeer-review

2 Scopus citations

Abstract

NBS1, also known as NBN, plays an important role in maintaining genomic stability. Interestingly, rs2735383 G > C, located in a microRNA binding site in the 3′-untranslated region (UTR) of NBS1, was shown to be associated with increased susceptibility to lung and colorectal cancer. However, the relation between rs2735383 and susceptibility to breast cancer is not yet clear. Therefore, we genotyped rs2735383 in 1,170 familial non-BRCA1/2 breast cancer cases and 1,077 controls using PCR-based restriction fragment length polymorphism (RFLP-PCR) analysis, but found no association between rs2735383CC and breast cancer risk (OR = 1.214, 95% CI = 0.936-1.574, P = 0.144). Because we could not exclude a small effect size due to a limited sample size, we further analyzed imputed rs2735383 genotypes (r 2 > 0.999) of 47,640 breast cancer cases and 46,656 controls from the Breast Cancer Association Consortium (BCAC). However, rs2735383CC was not associated with overall breast cancer risk in European (OR = 1.014, 95% CI = 0.969-1.060, P = 0.556) nor in Asian women (OR = 0.998, 95% CI = 0.905-1.100, P = 0.961). Subgroup analyses by age, age at menarche, age at menopause, menopausal status, number of pregnancies, breast feeding, family history and receptor status also did not reveal a significant association. This study therefore does not support the involvement of the genotype at NBS1 rs2735383 in breast cancer susceptibility.

Original languageEnglish
Article number36874
JournalScientific Reports
Volume6
DOIs
StatePublished - 15 Nov 2016

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Rs2735383, located at a microRNA binding site in the 3'UTR of NBS1, is not associated with breast cancer risk'. Together they form a unique fingerprint.

Cite this